Immunophotonics, Inc.

Immunophotonics, Inc. company information, Employees & Contact Information

Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid tumor cancers. IP-001 has unique physio-chemical and immunological properties that allows it to ignite a systemically active cancer immunotherapy from a routine tumor ablation; a minimal invasive intervention that destroys tumors and in doing so liberates tumor antigens. IP-001 enhances interactions of tumor antigens with the immune system, improves the motility of tumor infiltrating T cells, promotes their surveillance of tumor tissue and can generate long-term protective immunity.

Company Details

Employees
19
Founded
-
Address
Biogenerator Labs, Suite 212, 4340 Duncan Ave.,switzerland
Phone
636-675-6161
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
St. Louis, Missouri
Looking for a particular Immunophotonics, Inc. employee's phone or email?

Immunophotonics, Inc. Questions

News

Immunophotonics Completes Treatment of Last Patient in INJECTABL-1 Phase 1b/2a Clinical Trial of IP-001 for Advanced Solid Tumors - PR Newswire

Immunophotonics Completes Treatment of Last Patient in INJECTABL-1 Phase 1b/2a Clinical Trial of IP-001 for Advanced Solid Tumors PR Newswire

Immunophotonics Announces Issuance of U.S. Patent Covering Lead Drug Candidate - GlobeNewswire

Immunophotonics Announces Issuance of U.S. Patent Covering Lead Drug Candidate GlobeNewswire

Immunophotonics wins Startup World Cup's St. Louis regional with cancer-fighting drug - STLPR

Immunophotonics wins Startup World Cup's St. Louis regional with cancer-fighting drug STLPR

OU Engineer Chairs International Biophotonics Conference He Founded 20 Years Ago - The University of Oklahoma

OU Engineer Chairs International Biophotonics Conference He Founded 20 Years Ago The University of Oklahoma

St. Louis startup developing cancer-fighting drug raises $21M - KSDK

St. Louis startup developing cancer-fighting drug raises $21M KSDK

5 Biotechs Taking the Pipeline-in-a-Product Approach to Drug Development - BioSpace

5 Biotechs Taking the Pipeline-in-a-Product Approach to Drug Development BioSpace

Lu Alleruzzo, 28 - Co-founder and COO, Immunophotonics Inc. - The Business Journals

Lu Alleruzzo, 28 - Co-founder and COO, Immunophotonics Inc. The Business Journals

Biotech firm moves into business incubator - COMO Magazine

Biotech firm moves into business incubator COMO Magazine

Laser-like focus - Columbia Daily Tribune

Laser-like focus Columbia Daily Tribune

Top Immunophotonics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant